Monday, September 1, 2014

XTL hopes to begin major lupus trial next year

XTL hopes to begin major lupus trial next year

July 22, 2014 by · Leave a Comment 

Tweet XTL Biopharmaceuticals (NASDAQ:XTLB; TASE:XTL) is aiming to begin a Phase 2b clinical trial in the first half of 2015 with its hCDR1 peptide to treat patients with systemic lupus erythematosus (SLE). “We are in the process of finalizing our trial design, approaching the FDA and hope to have feedback from the agency before the […]

Novadaq highlights game changer for the OR

Novadaq highlights game changer for the OR

October 16, 2012 by · Leave a Comment 

Tweet With adoption of its SPY imaging technologies growing in operating rooms across North America, Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has embarked on a long-term growth plan to image nerves and cancer cells with tissue-binding reagents that could represent a paradigm shift in the OR. “The future of the installed base of SPY technologies will include […]

Analysts up Novadaq price target

Analysts up Novadaq price target

September 27, 2012 by · Leave a Comment 

Tweet Piper Jaffray and RBC Capital Markets raised their price targets on Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) following the company’s upbeat presentations at its “analyst and investor day” meeting in New York. Piper Jaffray raised its target on “overweight-rated” Novadaq to $14 from $10 while RBC moved its target to $12 (Canadian) from $7 and maintained its “sector perform” rating. […]

Novadaq partnering strategy hits marketing milestone

Novadaq partnering strategy hits marketing milestone

January 17, 2012 by · Leave a Comment 

Tweet Novadaq Technologies (TSX:NDQ), a maker of real-time fluorescence imaging products for the operating room, reached a significant milestone earlier this month when it named MAQUET Cardiovascular as the exclusive distributor of its CO2 Heart Laser system in the U.S. “We have now completed our strategic agenda of partnering each one of our first four […]

Email Newsletters with Constant Contact
Google+